Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00610181 · ClinicalTrials.gov registry record

Magnetic Resonance Imaging in Patients With Breast Cancer

A clinical trial of Breast Cancer, sponsored by M.D. Anderson Cancer Center.

Completed
Registry status
96
Enrollment target
1
Study location

NCT00610181: Completed study of Breast Cancer, sponsored by M.D. Anderson Cancer Center.

NCT00610181 is a study of Breast Cancer that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 96 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add start date to calendar (.ics) →

The verdict

NCT00610181, a study of Breast Cancer, has completed, sponsored by M.D. Anderson Cancer Center.

COMPLETED
Registry status
96 participants
Enrollment target
1
Study location

Study Summary

The goal of this clinical research study is to learn how often magnetic resonance imaging (MRI) of the breast locates additional areas of cancer in the breast of patients with lobular cancer as well as in the breasts of young breast cancer patients (less than age 40 years). Researchers also hope to learn how often the results of the MRI changes the type of surgical treatment that is recommended and understand the costs associated with using MRI in the diagnostic process. Researchers also want to use a different way of looking at the MRI scans to learn if they can more easily learn the difference between a cyst and a tumor.

Conditions Studied

Interventions

  • PROCEDURE MRI

Study Locations (1)

Texas

  • University of Texas MD Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 96 participants
Start Date 2008-01
M.D. Anderson Cancer Center

2,692 total trials

What the finished NCT00610181 record still lists

NCT00610181 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 96 participants, a relatively small participant target, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (97% lower).

The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which MRI is the first listed.

NCT00610181 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT00610181 about?

NCT00610181 is a clinical study titled "Magnetic Resonance Imaging in Patients With Breast Cancer". The goal of this clinical research study is to learn how often magnetic resonance imaging (MRI) of the breast locates additional areas of cancer in the breast of patients with lobular cancer as well as in the breasts of young breast cancer patients (less than age 40 years). Researchers also hope to ...

What is the current status of trial NCT00610181?

This trial is currently completed. The enrollment target is 96 participants. The study started on 2008-01.

What conditions does trial NCT00610181 study?

This clinical trial studies the following conditions: Breast Cancer.

What interventions are being tested in trial NCT00610181?

The interventions under investigation include: MRI (PROCEDURE).

Who is sponsoring clinical trial NCT00610181?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00610181 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00610181's enrollment target sits among peer trials

96 604th of 1224 higher than 618 of 1,224 other Breast Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03401762 · 96 participants · NA

    Wearable MCI to Reduce Muscle Co-activation in Acute and Chronic Stroke

  • NCT03471260 · 96 participants · Phase 1

    Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies

  • NCT03549559 · 96 participants · NA

    Imaging Histone Deacetylase in the Heart

  • NCT03841058 · 96 participants · Phase 2

    Abaloparatide vs. Placebo in Post-Menopausal Women and Abaloparatide in Men Receiving Initial Spinal Fusion Surgery

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00610181, the US trial registry maintained by the National Library of Medicine. NCT00610181 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.